IFP Advisors’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

IFP Advisors’s Portfolio TBIO Stock Details TBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-217	Closed	-$6K	–	3507
2021 Q2	$6K	Buy	217 +86	+66%	+$1.69K	﹤0.01%	2434
2021 Q1	$2K	Buy	131 +102	+352%	+$2.32K	﹤0.01%	2745
2020 Q4	$1K	Buy	+29	New	+$519	﹤0.01%	2862

IFP Advisors's TBIO Position: Q3 2021 in Review

IFP Advisors sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 217 shares — an estimated $6K sold.

IFP Advisors first reported a position in TBIO in Q4 2020 and held it in 3 quarters. The position peaked at $6K in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

IFP Advisors reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
IFP Advisors sold 217 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $6K.
IFP Advisors first reported a position in Translate Bio, Inc. Common Stock in Q4 2020 and held it in 3 quarters.
IFP Advisors's Translate Bio, Inc. Common Stock position peaked at $6K in Q2 2021.
0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on IFP Advisors's 13F filing for Q3 2021, filed 6 Oct 2021.